Teladoc Health (TDOC) reported a Q4 loss late Wednesday of $0.28 per diluted share, wider than a loss of $0.17 a year earlier.
Analysts polled by FactSet expected a loss of $0.26.
Revenue for the quarter ended Dec. 31 was $640.5 million, compared with $660.5 million a year earlier.
Analysts surveyed by FactSet expected $639.5 million.
The company said it expects a Q1 net loss of $0.40 to $0.15 per share on revenue of $608 million to $629 million. Analysts surveyed by FactSet expect a loss of $0.33 per share on revenue of $626.7 million.
For 2025, the company expects a loss between $1.10 to $0.50 per share on revenue of $2.47 billion to $2.58 billion. Analysts surveyed by FactSet expect a loss of $0.94 per share on revenue of $2.53 billion.
Shares of the company fell 15.5% in premarket activity Thursday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.